Resistentia Pharmaceuticals
Latest round
- Series C
Last raised
- Sep 2006
Total raised
- $14M
Investors
- 5
About Resistentia Pharmaceuticals
Resistentia Pharmaceuticals, is based in Sweden and is a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders.
Who invested in Resistentia Pharmaceuticals
5 investors across 1 round
See all investors in Resistentia Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Sep 26, 2006
Amount
$14M
Investors
Questions about Resistentia Pharmaceuticals
Who invested in Resistentia Pharmaceuticals?
Resistentia Pharmaceuticals has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Resistentia Pharmaceuticals raised?
Resistentia Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Resistentia Pharmaceuticals last raise money?
Resistentia Pharmaceuticals's most recent round on record is a Series C, in Sep 2006.
What does Resistentia Pharmaceuticals do?
Resistentia Pharmaceuticals, is based in Sweden and is a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders.
Where is Resistentia Pharmaceuticals headquartered?
Resistentia Pharmaceuticals is headquartered in Uppsala, Sweden.
Which VCs invest in companies like Resistentia Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Resistentia Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Resistentia Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.